Evidence map›Paper›PMID 32466543›Full record

ReviewBiomolecules2020

Zoopharmacology: A Way to Discover New Cancer Treatments.

Eva María Domínguez-Martín, Joana Tavares, Patrícia Rijo, Ana María Díaz-Lanza

Abstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Chemical Variability and Biological Potential ofMolecules (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Plants (Basel, Switzerland) · 2022
    Review
  7. Advancing Discovery of Snail Mucins Function and Application.Frontiers in bioengineering and biotechnology · 2021
    Review
  8. Paleomedicine and the Evolutionary Context of Medicinal Plant Use.Revista brasileira de farmacognosia : orgao oficial da Sociedade Brasileira de Farmacognosia · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Eva María Domínguez-MartínCBIOS-Center for Research in Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologías, Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0002-7884-4292
Joana TavaresCBIOS-Center for Research in Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologías, Campo Grande 376, 1749-024 Lisbon, Portugal.
Patrícia RijoCBIOS-Center for Research in Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologías, Campo Grande 376, 1749-024 Lisbon, Portugal.ORCID 0000-0001-7992-8343
Ana María Díaz-LanzaDepartment of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá, Carretera Madrid-Barcelona, Km 33.100, 28805 Alcalá de Henares, Madrid, Spain.

Funding

Fundação para a Ciência e a Tecnologia UID/DTP/04567/2020
6 · The paper itself

Abstract

Zoopharmacognosy is the multidisciplinary approach of the self-medication behavior of many kinds of animals. Recent studies showed the presence of antitumoral secondary metabolites in some of the plants employed by animals and their use for the same therapeutic purposes in humans. Other related and sometimes confused term is Zootherapy, which consists on the employment of animal parts and/or their by-products such as toxins, venoms, etc., to treat different human ailments. Therefore, the aim of this work is to provide a brief insight for the use of Zoopharmacology (comprising Zoopharmacognosy and Zootherapy) as new paths to discover drugs studying animal behavior and/or using compounds derived from animals. This work is focused on the approaches related to cancer, in order to propose a new promising line of research to overcome multidrug resistance (MDR). This novel subject will encourage the use of new alternative prospective ways to find new medicines.

Indexed as

Drug DiscoveryAnimalsAntineoplastic AgentsDrug Resistance, NeoplasmNeoplasmsAntineoplastic Agentszoopharmacology, zoopharmacognosy, zootherapy, cancer, multidrug resistance (MDR), collateral sensitivity, oncotherapy

Identifiers

PMID32466543
PMCPMC7356688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.